Page last updated: 2024-09-05

ak 295 and Brain Ischemia

ak 295 has been researched along with Brain Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, A; Baker, KL; Bartus, RT; Dean, RL; Elliott, PJ; Harbeson, SL; Hayward, NJ; Li, Z; Sawyer, SD; Straub, JA1
Andersson, AL; Bahr, BA; Blomgren, K; Hagberg, H; Hallin, U; Kawashima, S; McRae, A; Puka-Sundvall, M; Saido, TC1

Other Studies

2 other study(ies) available for ak 295 and Brain Ischemia

ArticleYear
Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.
    Stroke, 1994, Volume: 25, Issue:11

    Topics: Animals; Brain Ischemia; Calpain; Dipeptides; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley

1994
Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia.
    The Journal of biological chemistry, 1999, May-14, Volume: 274, Issue:20

    Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Calcium-Binding Proteins; Calpain; Cell Membrane; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Female; Functional Laterality; Hypoxia; Male; Rats; Rats, Wistar; Up-Regulation

1999